Therefore, it is possible that LCL85 sensitizes tumor cells to Fas-mediated apoptosis at least in part through inducing C16 ceramide accumulation, resulting in ceramide-mediated xIAP and cIAP1 proteasomal degradation. The gene discussed is XIAP; the disease is neoplasm.